Clinical Trial Update: Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating the efficacy, safety and tolerability of TRI476 (oxcarbazepine) in children with inadequately controlled partial onset seizures. Resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial-onset Seizures

Drugs mentioned

• TRI476 (Oxcarbazepine) (Oxcarbazepine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Partial Onset Seizures | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-01-24